$718 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 87.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DVA | New | DAVITA INC | $51,192,000 | – | 450,000 | +100.0% | 7.13% | – |
GH | Buy | GUARDANT HEALTH INC | $44,034,000 | +85.4% | 440,255 | +131.7% | 6.14% | +80.0% |
CTLT | Buy | CATALENT INC | $40,542,000 | +17.2% | 316,661 | +21.8% | 5.65% | +13.8% |
ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $38,374,000 | +87.4% | 632,189 | +96.9% | 5.35% | +82.0% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $36,734,000 | +184.3% | 170,000 | +142.9% | 5.12% | +176.1% |
NVRO | Buy | NEVRO CORP | $34,233,000 | -27.1% | 422,260 | +4.7% | 4.77% | -29.2% |
NSTG | New | NANOSTRING TECHNOLOGIES INC | $31,673,000 | – | 750,000 | +100.0% | 4.41% | – |
UNH | New | UNITEDHEALTH GROUP INC | $30,128,000 | – | 60,000 | +100.0% | 4.20% | – |
SGRY | New | SURGERY PARTNERS INC | $29,039,000 | – | 543,696 | +100.0% | 4.05% | – |
ICUI | New | ICU MED INC | $27,177,000 | – | 114,506 | +100.0% | 3.79% | – |
CRL | Buy | CHARLES RIV LABS INTL INC | $26,375,000 | +70.9% | 70,000 | +87.1% | 3.68% | +65.9% |
ALGN | Buy | ALIGN TECHNOLOGY INC | $26,287,000 | +12.9% | 40,000 | +14.3% | 3.66% | +9.6% |
AHCO | New | ADAPTHEALTH CORP | $17,122,000 | – | 700,000 | +100.0% | 2.39% | – |
Buy | SOMALOGIC INC | $16,730,000 | +323.8% | 1,437,246 | +351.0% | 2.33% | +311.1% | |
LH | New | LABORATORY CORP AMER HLDGS | $15,711,000 | – | 50,000 | +100.0% | 2.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
ICON PLC | 10 | Q3 2023 | 11.7% |
BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
NEVRO CORP | 10 | Q1 2022 | 6.7% |
DEXCOM INC | 10 | Q3 2023 | 7.7% |
ABBVIE INC | 9 | Q3 2023 | 8.1% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.